Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEST-BAO: EVT +/- Alteplase in Basilar Artery Occlusion
NCT05631847Completed
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Apr 2023
- Primary completion
- Aug 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Proportion of patients achieving modified Rankin Scale score <= 2 at 90 days. Started Apr 2023; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05631847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05631847.